Identifiez-vous
Groupes
Chercheurs
Résultats
HOSPITAL UNIVERSITARIO RUBER
Département
First Hospital of Jilin University
Changchun, China
Tu es dans
Collaborations
First Hospital of Jilin University
Publications en collaboration avec des chercheurs de First Hospital of Jilin University (2)
2023
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
The Lancet, Vol. 401, Núm. 10371, pp. 105-117
2016
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 17, Núm. 3, pp. 357-366
Contacter
Avertissement légal
Aide
translate
fr
arrow_drop_down
translate
fr
arrow_drop_down
es
ca
eu
gl
en
de